Claritev Corp Reports Third‑Quarter 2025 Results

Claritev Corp, a technology‑driven health‑care data and insights company, released its third‑quarter earnings on November 7, 2025. The company, listed on the New York Stock Exchange under the ticker CLTI, has positioned itself as a provider of cost‑management solutions, payment integrity services, and analytics for health‑care networks, primarily serving clients in the State of New York.

Financial Highlights

  • GAAP Earnings per Share (EPS): The company posted a GAAP EPS of ‑$4.23, falling short of analysts’ expectations by $0.68.
  • Revenue: Claritev generated $246 million in revenue, $9.29 million above the consensus estimate.
  • Revenue Drivers: The stronger revenue figure was attributed to increased uptake of the company’s cost‑management platforms and expanded data‑analytics contracts across the New York market.

Market Context

The company’s stock closed at $61.96 on November 5, 2025, after a volatile year that saw a 52‑week low of $4.80 and a 52‑week high of $74.07. With a market capitalization of approximately $1.07 billion, Claritev’s valuation remains sensitive to earnings performance, reflected in its current price‑to‑earnings ratio of ‑1.61.

Strategic Outlook

In the accompanying press release, Claritev’s management emphasized its commitment to expanding transparency and affordability in health‑care. The company highlighted ongoing investments in technology to enhance payment integrity and data‑analytics capabilities, aiming to strengthen its competitive position in a rapidly evolving health‑care technology landscape.

Investor Reactions

  • Analyst Coverage: Prior to the earnings announcement, Benzinga reported a preview of Claritev’s results, noting that investors were particularly focused on the company’s ability to convert its revenue growth into profitability.
  • Capital Movements: Earlier this month, a separate filing confirmed that Claritev had received an investment from Klaim, a fintech partner, underscoring confidence in Claritev’s strategic direction.

Bottom Line

Claritev’s third‑quarter performance illustrates a continued trend of revenue growth offset by persistent earnings deficits. The company’s ability to sustain higher revenue while working toward profitability will be a key metric for investors and analysts moving forward.